Markets

Ahead of Wall Street - December 21, 2011 - Ahead of Wall Street

Wednesday, December 21, 2011

Stocks will find it hard to replicate Tuesday's strong performance, given concerns about the Euro-zone banking system following the bigger-than-expected refinancing operation by the European Central Bank (ECB). Oracle's ( ORCL ) earnings miss will also likely weigh on market sentiment by raising doubts about the upcoming earnings season.

The expectation was for the ECB to provide roughly €300 billion in funding to Euro-zone banks, while the actual amount turned out to be €489 billion. The bigger amount could be interpreted as giving Euro-zone banks greater ability to buy government bonds. But the more likely explanation is that the increased demand for this type of financing is indicative of stress in the Euro-zone financial system, prompting the banks to tap this cheap source of funding. The modest uptick in Italian yields following the ECB action bears out this latter explanation.

In corporate news, Oracle's earnings miss will remain in the spotlight today. We also have negative earnings surprises from Walgreens ( WAG ) and CarMax ( KMX ), while Nike ( NKE ) came ahead.

Sheraz Mian

Director of Research

CARMAX GP (CC) ( KMX ): Free Stock Analysis Report

NIKE INC-B ( NKE ): Free Stock Analysis Report

ORACLE CORP ( ORCL ): Free Stock Analysis Report

WALGREEN CO ( WAG ): Free Stock Analysis Report

To read this article on Zacks.com click here.

Zacks Investment Research

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.


The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

In This Story

ORCL KMX NKE

Other Topics

US Markets

Latest Markets Videos

    Zacks

    Zacks is the leading investment research firm focusing on stock research, analysis and recommendations. In 1978, our founder discovered the power of earnings estimate revisions to enable profitable investment decisions. Today, that discovery is still the heart of the Zacks Rank. A wealth of resources for individual investors is available at www.zacks.com.

    Learn More